ABH Healthcare IPO Day 1: GMP ₹0

Hello investors! We’re diving into the first day of the ABH Healthcare SME IPO on the NSE, and it’s a quiet start. As of the end of Day 1, the subscription numbers are sitting at a flat zero across all categories – Retail, NII, and QIB. This means not a single share has been bid for yet. With the issue price set at ₹102 and the IPO period running from August 24th to August 26th, 2026, there’s still plenty of time for things to pick up. The lot size is 1200 shares, so that’s what potential investors are looking at.

Subscription Status

Let’s break down what these zero subscription numbers really mean. When you see 0x across Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers) on Day 1, it’s not necessarily a cause for alarm just yet, especially for an SME IPO. Typically, retail investors often wait until the latter half of the subscription period to apply, wanting to see how the institutional segments are performing. The absence of QIB and NII bids on Day 1 could indicate that these larger players are also taking their time, perhaps conducting their due diligence or waiting for more clarity as the IPO progresses. It’s common for the real action to kick off from Day 2 onwards. However, if these numbers don’t change significantly by Day 2, it might start to raise a few eyebrows. For now, it’s a wait-and-watch game.

GMP Update

Now, let’s talk Grey Market Premium (GMP). The current GMP for ABH Healthcare IPO is ₹0. This is unchanged from yesterday’s GMP, which was also ₹0. What does a ₹0 GMP signify? It suggests that the market sentiment, as reflected in the unofficial grey market, is neutral. Investors are not willing to pay an extra premium over the issue price of ₹102. This aligns with the subscription numbers we’re seeing – no strong demand, no premium. The expected listing price is currently pegged at the issue price itself, ₹102. This means that based on the GMP, investors aren’t anticipating a significant listing gain right now. It’s important to remember that GMP is an unofficial indicator and can change rapidly, but a steady ₹0 GMP on Day 1 of subscription, coupled with zero subscription, paints a picture of cautious sentiment.

Should You Apply?

So, the big question: should you apply for the ABH Healthcare IPO? Based on the data from Day 1, it’s a mixed bag. The zero subscription numbers and the ₹0 GMP suggest a lack of immediate investor enthusiasm. This could be due to various factors, including the company’s fundamentals, the overall market conditions, or simply the fact that it’s only Day 1. For conservative investors, this might be a signal to wait and observe how the subscription progresses over the next two days. If you’re looking for quick listing gains, the current GMP doesn’t offer much promise. However, if you believe in the long-term prospects of ABH Healthcare and its business model, the current situation might present an opportunity to get in at the issue price without much competition, provided you’ve done your homework. As per SEBI advisor guidelines, it’s always prudent to conduct thorough research on the company’s financials, its industry, and its management before making any investment decisions. Don’t just rely on GMP or initial subscription numbers. You can find more detailed information and analysis on the ABH Healthcare IPO here: View Full ABH Healthcare IPO Details. Remember, investing in the stock market carries risks, and it’s essential to invest within your risk tolerance.